Biofrontera AG
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Biofrontera AG
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.
Frequently asked questions
To buy Biofrontera AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Biofrontera AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Biofrontera AG is B8FK:xetr. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Biofrontera AG has its primary listing on Deutsche Börse (XETRA). You can trade Biofrontera AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Biofrontera AG is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Biofrontera AG as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Biofrontera AG.